don't want to give a forecast now because the stock is still in a somewhat problematic area,
but you can take a look at the attached picture
Nice volume today
to follow...
Not a recommendation of course...
The only way to trade the stock market... continued in my signature below
NASDAQ:VERV
Like many other recent IPOs, Verve Therapeutics set up in a nice technical base and is now beginning to break out. A series of lower lows shows that volume is drying up as pullbacks became shallower - a sign the stock is moving from weak hands to strong hands.
IPO intraday trading strategy idea
Verve Therapeutics is genetic medicines company pioneering a new approach to the care of cardiovascular disease, or CVD, transforming treatment from chronic management to single-course gene editing medicines.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher...
